社区老年人肌少症三年不良健康结局:五种诊断定义比较
SarcoPhAge前瞻性队列纳入534名社区老年人(73.5±6.2岁,60.5%女性),随访3年,比较五种肌少症定义下基线肌少症与身体残疾、机构化和死亡的关系。基线肌少症与身体残疾或机构化无显著关联,但肌少症组死亡比例更高(16.2% vs 4.6%,P<.001),3年内死亡风险约增至3倍。不同定义预测结局的能力存在差异。
要点
- 社区老年人基线肌少症与3年内死亡风险升高相关,死亡比例16.2% vs 4.6%。
- 基线肌少症与身体残疾或机构化未见显著关联。
- 五种肌少症定义预测不良结局的能力存在差异。
核心结论
- 在3年随访期内,基线肌少症与死亡风险升高相关。
- 不同肌少症定义预测结局的能力存在一定差异。
研究设计与样本
- 研究为SarcoPhAge纵向项目的一部分,前瞻性队列纳入534名社区老年人(73.5±6.2岁,60.5%女性)。
- 肌少症定义为低肌肉量加肌肉功能下降,每年随访或电话收集不良结局,采用Cox比例风险模型或logistic回归分析关联。
主要发现
- 3年后33名参与者失访。
- 肌少症组死亡比例为16.2%,非肌少症组为4.6%,P<.001。
- 基线肌少症与身体残疾或机构化未见显著关联。
- 伴肌少症者3年内死亡概率约为无肌少症者的3倍。
临床怎么用
- 社区老年人评估肌少症时,可将死亡风险增高作为重要不良结局进行监测。
- 不同肌少症定义预测结局能力存在差异,临床解读诊断结果时需考虑所用定义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the occurrence of 3 major adverse outcomes of sarcopenia (ie, physical disabilities, institutionalizations and deaths) observed over a 3-year follow-up in older adults and compare the risk of these outcomes using 5 definitions of sarcopenia. DESIGN: The study is a part of the ongoing SarcoPhAge (for Sarcopenia and Physical Impairment with advancing Age) longitudinal project. SETTING AND PARTICIPANTS: The SarcoPhAge study follows 534 community-dwelling older adults. MEASURES: Sarcopenia was defined as low muscle mass plus a decreased muscle function. Data on adverse outcomes were collected yearly during the annual follow-up or with a phone call. The association between baseline sarcopenia and the occurrence of undesirable outcomes was tested using the Cox proportional hazards model or a logistic regression model. RESULTS: A total of 534 subjects were recruited into this prospective cohort (73.5 ± 6.2 years, 60.5% female). After 3 years, 33 participants were lost to follow-up. If no association between baseline sarcopenia and physical disabilities or institutionalizations was highlighted, a higher number of deaths occurred in individuals diagnosed with sarcopenia than in those who were not diagnosed (16.2% vs 4.6%, P value <.001). The probability of death within 3 years when presenting with sarcopenia showed an approximately 3-fold increase compared to subjects without sarcopenia. CONCLUSION: Over a 3-year period, sarcopenia at baseline was associated with an increased risk of mortality. There were some variations in the ability of different definitions of sarcopenia to predict outcomes.
引用
- Locquet M, Beaudart C, Hajaoui M, et al. Three-Year Adverse Health Consequences of Sarcopenia in Community-Dwelling Older Adults According to 5 Diagnosis Definitions. J Am Med Dir Assoc. 2018. PMID: 30032996. doi:10.1016/j.jamda.2018.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。